1,150 results on '"Brunner, Hermine"'
Search Results
2. Correction: S100 proteins as potential predictive biomarkers of abatacept response in polyarticular juvenile idiopathic arthritis
3. S100 proteins as potential predictive biomarkers of abatacept response in polyarticular juvenile idiopathic arthritis
4. Renal disease in pediatric rheumatology
5. Towards a novel clinical outcome assessment for systemic lupus erythematosus: first outcomes of an international taskforce
6. Urine biomarker score captures response to induction therapy with lupus nephritis
7. Validation of the ankle-specific pediatric arthritis ultrasound scoring system in children with juvenile idiopathic arthritis
8. The 4th NextGen therapies for SJIA and MAS: part 3 clinical trials in refractory SJIA: historic controls as an alternative to a withdrawal design study
9. Acute kidney injury requiring kidney replacement therapy in childhood lupus nephritis: a cohort study of the Pediatric Nephrology Research Consortium and Childhood Arthritis and Rheumatology Research Alliance
10. Systemic Lupus Erythematosus
11. Baricitinib in juvenile idiopathic arthritis: an international, phase 3, randomised, double-blind, placebo-controlled, withdrawal, efficacy, and safety trial
12. Long‐Term Maintenance of Clinical Responses by Individual Patients With Polyarticular‐Course Juvenile Idiopathic Arthritis Treated With Abatacept
13. Preclinical characterization of the Toll-like receptor 7/8 antagonist MHV370 for lupus therapy
14. Safety and efficacy of tofacitinib for the treatment of patients with juvenile idiopathic arthritis: preliminary results of an open-label, long-term extension study
15. Pilot study comparing the childhood arthritis and rheumatology research alliance consensus treatment plans for induction therapy of juvenile proliferative lupus nephritis
16. Evaluating the Construct of Damage in Systemic Lupus Erythematosus
17. Juvenile idiopathic arthritis
18. Long-term efficacy and safety of subcutaneous tocilizumab in clinical trials of polyarticular or systemic juvenile idiopathic arthritis.
19. Metrics and Outcome Measures of Disease Activity and Damage in Childhood-Onset Systemic Lupus Erythematosus
20. Tofacitinib in juvenile idiopathic arthritis: a double-blind, placebo-controlled, withdrawal phase 3 randomised trial
21. Stability of Novel Urinary Biomarkers Used for Lupus Nephritis: PUB280
22. Successful Urine Multiplex Bead Assay to Measure Lupus Nephritis Activity
23. Transancestral mapping and genetic load in systemic lupus erythematosus.
24. Immunomodulatory effects of cytokine-induced expansion of cytotoxic lymphocytes in a mouse model of lupus-like disease
25. Revisiting Childhood-Onset Systemic Lupus Erythematosus.
26. Children With Enthesitis‐Related Arthritis and Possible Benefits From Treatments for Adults With Spondyloarthritis
27. Safety and effectiveness of abatacept in juvenile idiopathic arthritis: results from the PRINTO/PRCSG registry
28. The 4th NextGen therapies for SJIA and MAS: part 3 clinical trials in refractory SJIA: historic controls as an alternative to a withdrawal design study
29. Secondary analysis of APPLE study suggests atorvastatin may reduce atherosclerosis progression in pubertal lupus patients with higher C reactive protein
30. Clinicopathologic Conference: A Four‐Year‐Old Child With Digital Clubbing
31. Practice Analysis and Determining the Knowledge and Skills Expected of a Pediatric Rheumatologist
32. Baricitinib in juvenile idiopathic arthritis: an international, phase 3, randomised, double-blind, placebo-controlled, withdrawal, efficacy, and safety trial
33. Cancer risk in childhood-onset systemic lupus
34. Pediatric and Neonatal Lupus
35. Evolution in the Understanding of Pediatric‐Onset Axial Spondyloarthritis
36. Childhood-Onset Systemic Lupus Erythematosus: A Review and Update
37. Cancer risk in childhood-onset systemic lupus.
38. Urine biomarkers of chronic kidney damage and renal functional decline in childhood-onset systemic lupus erythematosus
39. The effects of early aggressive therapy in JIA: results of the TREAT study
40. Abatacept as Monotherapy and in Combination With Methotrexate in Patients With Juvenile Idiopathic Arthritis: Analysis of 2 Phase III Trials
41. Treatment patterns in paediatric and adult patients with SLE: a retrospective claims database study in the USA
42. LO-033 Towards a novel clinical outcome assessment for systemic lupus erythematosus trials – first outcomes of an international consensus process
43. Usefulness of the lupus low disease activity state as a treatment target in childhood-onset SLE
44. Race, Income, and Disease Outcomes in Juvenile Dermatomyositis
45. Cerebral microvascular and microstructural integrity is regionally altered in patients with systemic lupus erythematosus
46. Prevalence of co-existing autoimmune disease in juvenile idiopathic arthritis: a cross-sectional study
47. The use of S100 proteins testing in juvenile idiopathic arthritis and autoinflammatory diseases in a pediatric clinical setting: a retrospective analysis
48. The 4th NextGen therapies for SJIA and MAS: part 3 clinical trials in refractory SJIA: historic controls as an alternative to a withdrawal design study.
49. The American English version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)
50. Therapeutics Development in Polyarticular Course Juvenile Idiopathic Arthritis (pcJIA): Extrapolation, Dose Selection and Clinical Trial Design; Workshop Proceedings and Recent Updates
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.